MedPath

湖南柏齐鹤药物研发有限公司

Ownership
-
Established
2021-05-11
Employees
-
Market Cap
-
Website
www.baiqihe.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20254184
Approval Date
May 13, 2025
NMPA

Piperacillin Sodium for Injection

Product Name
注射用哌拉西林钠
Approval Number
国药准字H20253335
Approval Date
Feb 8, 2025
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20244764
Approval Date
Aug 27, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.